Anacor Pharmaceuticals (ANAC)

5.84 -0.25  -4.11%  May 20, 2:20PM
Add to Watchlists Create an Alert

Anacor Pharmaceuticals Cash from Operations Quarterly:

-11.41M for Dec. 31, 2012
View Full Chart

Anacor Pharmaceuticals Cash from Operations Quarterly Chart

    Anacor Pharmaceuticals Historical Cash from Operations Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -11.41M
    Sept. 30, 2012 -15.06M
    June 30, 2012 -15.87M
    March 31, 2012 -12.60M
    Dec. 31, 2011 -12.32M
    Sept. 30, 2011 -7.573M
    June 30, 2011 -12.85M
    March 31, 2011 -2.96M
    Dec. 31, 2010 -4.66M
       
    Sept. 30, 2010 10.90M
    June 30, 2010 -1.188M
    March 31, 2010 -8.231M
    Sept. 30, 2009 -25.04M
    June 30, 2009 -16.07M
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro

    About Cash From Operations

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

    Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
    Learn More

    Get data for

    ANAC Cash from Operations Quarterly Benchmarks

    Companies
    Valeant Pharmaceuticals International 255.35M
    QLT -9.286M
    Santarus -0.201M

    ANAC Cash from Operations Quarterly Rankings

    Overall 48th percentile
    4123 of 8002
    Sector 27th percentile
    474 of 650 in Healthcare
    Industry 35th percentile
    154 of 237 in Biotechnology

    ANAC Cash from Operations Quarterly Range, Past 5 Years

    Minimum -25.05M Sep 2009
    Maximum 10.90M Sep 2010
    Average -9.638M